Innopharma Technology
@InnopharmaTech
We’re bringing the future of manufacturing forward!
Looking forward to the PMTC Knowledge Day this 30th Nov! Featuring Chris O'Callaghan showcasing a SmartX install & Sean Costello on an expert panel discussing small molecule manufacturing challenges and findings of our digital maturity and sustainability DMSA of the sector.
Computational Fluid Dynamics - PMTC Knowledge Day 2021 In Stream A we discuss "PMTC Cleaning Research & Computational Fluid Dynamics Industrial Challenges". To register and learn more visit: lnkd.in/exjDu9GB
We're excited to announce a joined live Eyecon2 demo with @HScientific! We'll demo our real-time image particle size analyzer and show how it compares to sieve analysis and other correlation methods. We hope to see you there! 🎥 bit.ly/3cvOwRj"
SME Day, 25 March 2021, delighted to be sharing our key research themes and learning with our SME members
Pharma is primed to capitalize on in-line analytical data for faster formulation development and automated control in commercial manufacturing. Check out our study where we detail how #PAT can help to build a smart automation strategy!💊 bit.ly/2Z7bJ4Z
2020 will be remembered as a year with many challenges that disrupted both our professional and personal lives. Now let's look forward to a brighter New Year! From everyone at Innopharma Technology, we wish you a merry and safe Christmas and a Happy New Year❄️
PSD substantially impacts many factors in OSD. Controlling and monitoring PSD in your process is among the highest priority in the pharmaceutical industry. We've put together a handy guide to help you! 💊 bit.ly/3mvOvyK #Industry40 #Pharmaceuticalmanufacturing #PAT
We're excited to announce a joint #webinar with HORIBA Scientific! This webinar will cover modern particle characterization techniques like image analysis. We hope to see you there! 🎥 register.gotowebinar.com/register/37484… #PAT #SmartManufacturing #Industry40 #ImageAnalysis
Multiparticluates provide benefits in formulation flexibility such as immediate-release and sustained-release from a single dosage form. Our guide demonstrates the benefits of using PAT for multiparticulate development and control, along with best practice bit.ly/2VoLwNe
Just one day to go before our upcoming #webinar! We'll showcase the latest developments in pharmaceutical OSD control strategy using a real-world example of the benefits of going next-gen with OSD control strategy. Register now 🎥 my.demio.com/ref/dZkd6JTSmg… #Industry40
With just over a week to go before our upcoming #webinar showcasing the latest developments in pharmaceutical OSD control strategy, we wanted to share a sneak peek of what's in store! 🎥 Register now and join us: my.demio.com/ref/dZkd6JTSmg… #Pharmaceuticalmanufacturing
Join us on November 19th where Chris O’Callaghan will talk about current process applications, those in development, and present a real-world example demonstrating advanced process control possibilities 🎥 my.demio.com/ref/dZkd6JTSmg…
Do we have the manufacturing capability to rapidly scale production of a COVID-19 vaccine? We outline a means of overcoming traditional hurdles in vaccine production by embracing cutting-edge technologies 🦠bit.ly/35FZMWw #COVID19 #SmartManufacturing
The scale of data being generated today has never been higher, but how do we make sense of it all, and make it useful to you, the human? We explore how you can get powerful quality benefits by taking a human-centric approach to data 🧍⚙️#Pharma40 #Quality bit.ly/36pvsBJ
Quality 4.0 digitises the QA and QC departments, reducing burden, offering greater process robustness, and allowing for Continuous Process Verification (CPV). Check out the rest of the quality benefits in our latest blog! 💊#Pharma40 #Quality bit.ly/3l0kqXw
We're busy breaking down the meaning of ATEX labels. In the second blog of our 2-part series, we explain how ATEX classifications, markings and zones work. Come check it out! 📑 bit.ly/2G6jAtA #ATEX #PharmaceuticalManufacturing #SmartManufacturing #Industry40 #Pharma40
AstraZeneca and the University of Oxford are developing one of the most promising #covid19 vaccines. In a deal worth $331M, Samsung Biologics will supply bulk drug substance and drug product to support AstraZeneca's biologics therapeutics💊bit.ly/3mKkhJw
We're often surrounded by ATEX, but what does it really mean? We set about demystifying all things ATEX in the first of our 2-part series. Check it out! 📑 bit.ly/32PFFVI #Industry40 #Pharma40
We're excited to share our recent publication in Pharma Focus Asia! SmartCrys, that is set to revolutionise the pharma industry. We can expect more reliable, innovative and economical medication in the future! 💊 #Industry40 bit.ly/2FVydzo
Today's the day! Join us this evening for our #webinar with HORIBA and Colorcon® where we'll discuss how to modernise formulation and multiparticulate performance through computational design and process analytical technology 🎥💊register.gotowebinar.com/register/62469… #Industry40 #PAT
Less than 1 week left to register for our upcoming #webinar with Horiba and Colorcon where we'll discuss new age ways to build robust formulations and predict multiparticulate performance with cutting-edge PAT systems! Register and join us! 🎥💊 register.gotowebinar.com/register/62469…
United States Trends
- 1. Porzingis N/A
- 2. Kuminga N/A
- 3. Warriors N/A
- 4. Skubal N/A
- 5. Gonzaga N/A
- 6. #AEWDynamite N/A
- 7. Hield N/A
- 8. Dalen Terry N/A
- 9. Podz N/A
- 10. Knicks N/A
- 11. Jokic N/A
- 12. Tigers N/A
- 13. Ty Jerome N/A
- 14. Trey Murphy N/A
- 15. Andrade N/A
- 16. Yabu N/A
- 17. Doug Christie N/A
- 18. Brandon Garrison N/A
- 19. Golden State N/A
- 20. Brunson N/A
Something went wrong.
Something went wrong.